bisoprolol + aspirin

This drug is a fixed-dose combination (FDC) product containing bisoprolol and aspirin, developed by Athena Pharmaceutiques as an oral capsule. Bisoprolol is a cardioselective beta-1 adrenergic receptor blocker that reduces heart rate and myocardial contractility, primarily used to manage hypertension and ischemic heart disease. Aspirin (acetylsalicylic acid) is a non-steroidal anti-inflammatory drug (NSAID) that acts as an irreversible inhibitor of cyclooxygenase-1 (COX-1), providing antiplatelet effects to prevent thrombotic events. The combination is specifically indicated for patients with essential hypertension and/or ischemic heart disease who require both medications. By combining these two agents into a single daily capsule (available in doses of 5-10 mg bisoprolol and 75-100 mg aspirin), the product aims to improve patient adherence and reduce pill burden in the management of cardiovascular and cardio-metabolic conditions.

Brand names

BisoASS APONTISBisoASS

Other names

bisoprolol fumarate + acetylsalicylic acidbisoprolol/aspirin FDCbisoprolol + aspirin-Athena Pharmaceutiques